RNS Number : 1477U
Circassia Group Plc
31 March 2021
 

Circassia Group plc

Block Listing Interim Review

 

Oxford, UK - 31 March 2021: Circassia Group plc ("Circassia" or "the Company") (LSE: CIR), a medical device company focused on respiratory diagnostics and monitoring, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

 

Name of the company:

Circassia Group plc

Name of relevant scheme:

1)   Circassia EMI Share Option Scheme

2)   Circassia 2007 Unapproved Share Scheme

3)   Circassia 2014 Performance Share Plan Scheme

4)   Circassia 2015 Performance Share Plan Scheme

5)   Circassia 2016 Performance Share Plan Scheme

6)   Circassia 2017 Performance Share Plan Scheme

Period of return:

From:

1 October 2020

To:

31 March 2021

Balance of unallotted securities under scheme(s) from previous return:

1)   700,750

2)   203,000

3)   76,676

4)   251,864

5)   739,905

6)   678,980

Total: 2,651,175

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1) - 6) inclusive: Nil

Less:   Number of securities issued/allotted under scheme(s) during period:

1) - 3) inclusive: Nil

4)   (13,845)

5)   (30,362)

6)   (281,684)

Total: (325,891)

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

1)   700,750

2)   203,000

3)   76,676

4)   238,019

5)   709,543

6)   397,296

Total: 2,325,284

Number and class of securities originally listed and the date of admission:

1)   2,600,000 - 20 March 2014

2)   516,000 - 1 June 2017

3)   500,000 - 1 June 2017

4)   400,000 - 21 May 2018

5)   930,000 - 1 July 2019

6)   980,000 - 22 May 2020

 

For further information, please contact:

Circassia

Sarah Duncan, Company Secretary

 

Tel:  +44(0)1865 405566

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Jen Boorer / Hannah Woodley  

 

Tel: +44 (0) 20 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRMZGFFMMZGMZM